This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Differences in the Relative Amounts of Corticosterone and Hydrocortisone Secreted and in Their Biologic Effects

EDWARD H. KASS, M.D., Ph.D.; OSCAR HECHTER, Ph.D.; THOMAS W. MOU, M.D.; MAX B. LURIE, M.D.

AMA Arch Intern Med. 1955;96(3):397-402.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The predominant adrenal steroids of all animal species that have been studied are hydrocortisone (17-hydroxycorticosterone, Cortisol, Kendall's Compound F) and corticosterone (Kendall's Compound B). The close association of these two steroids in different animal species has been studied extensively by Bush,¹ who found that the ratios of hydrocortisone to corticosterone in the adrenal vein blood were different for different animal species (Table 1). The data with respect to man are as yet incomplete, but the evidence suggests that the human adrenal cortex secretes hydrocortisone predominantly.

Despite many similar metabolic effects of hydrocortisone and corticosterone, and the efficacy of either drug in the treatment of adrenocortical insufficiency, ² hydrocortisone is active in the treatment of clinical inflammatory disorders but corticosterone is inactive at the same dosage levels in the treatment of rheumatoid arthritis.³

The comparative effects of corticosterone and hydrocortisone on some aspects of resistance to infection were studied in the . . . [Full Text PDF of this Article]

Author Affiliations
Boston; Worcester, Mass.; Rochester, N. Y.; Philadelphia

From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, Department of Medicine, Harvard Medical School (Drs. Kass and Mou); the Worcester Foundation for Experimental Biology (Dr. Hechter), and the Henry Phipps Institute, University of Pennsylvania (Dr. Lurie). Present address of Dr. Mou: Strong Memorial Hospital.

Footnotes
Submitted for publication June 10, 1955.

Presented at the Sixty-Eighth Annual Meeting of the Association of American Physicians at Atlantic City, N. J., May 3, 1955.

Aided by grants from the U. S. Public Health Service; Lederle Laboratories Division, American Cyanamid Company; Pfizer Laboratories, Division of Chas. Pfizer & Company, Inc.; The Research and Development Division, Office of the Surgeon General. Department of the Army; the Commonwealth Fund, and the National Tuberculosis Association.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?